Manzanero-Ortiz S, Franco M, Laxmeesha M, Carmena A
iScience. 2024; 27(11):111118.
PMID: 39524346
PMC: 11546965.
DOI: 10.1016/j.isci.2024.111118.
Bhattacharjya D, Sivalingam N
Naunyn Schmiedebergs Arch Pharmacol. 2024; 397(11):8445-8475.
PMID: 38878089
DOI: 10.1007/s00210-024-03189-2.
Gao W, Zhou J, Morshedi M
Cancer Cell Int. 2024; 24(1):163.
PMID: 38725047
PMC: 11084024.
DOI: 10.1186/s12935-024-03338-w.
Larue A, Atlasi Y
Stem Cells. 2024; 42(6):509-525.
PMID: 38597726
PMC: 11177158.
DOI: 10.1093/stmcls/sxae027.
Chao S, Yan H, Bu P
Cell Regen. 2024; 13(1):5.
PMID: 38411768
PMC: 10897644.
DOI: 10.1186/s13619-024-00188-9.
Notch receptor/ligand diversity: contribution to colorectal cancer stem cell heterogeneity.
Brisset M, Mehlen P, Meurette O, Hollande F
Front Cell Dev Biol. 2023; 11:1231416.
PMID: 37860822
PMC: 10582728.
DOI: 10.3389/fcell.2023.1231416.
Targeting intratumor heterogeneity suppresses colorectal cancer chemoresistance and metastasis.
Chao S, Zhang F, Yan H, Wang L, Zhang L, Wang Z
EMBO Rep. 2023; 24(8):e56416.
PMID: 37338390
PMC: 10398666.
DOI: 10.15252/embr.202256416.
YY2-DRP1 Axis Regulates Mitochondrial Fission and Determines Cancer Stem Cell Asymmetric Division.
Wei M, Nurjanah U, Li J, Luo X, Hosea R, Li Y
Adv Sci (Weinh). 2023; 10(23):e2207349.
PMID: 37300334
PMC: 10427375.
DOI: 10.1002/advs.202207349.
A concise review on miRNAs as regulators of colon cancer stem cells and associated signalling pathways.
Banerjee A, Deka D, Muralikumar M, Sun-Zhang A, Bisgin A, Christopher C
Clin Transl Oncol. 2023; 25(12):3345-3356.
PMID: 37086351
DOI: 10.1007/s12094-023-03200-x.
Distinct but interchangeable subpopulations of colorectal cancer cells with different growth fates and drug sensitivity.
Coppo R, Kondo J, Iida K, Okada M, Onuma K, Tanaka Y
iScience. 2023; 26(2):105962.
PMID: 36718360
PMC: 9883198.
DOI: 10.1016/j.isci.2023.105962.
Cancer Stem Cells-The Insight into Non-Coding RNAs.
Bryl R, Piwocka O, Kawka E, Mozdziak P, Kempisty B, Knopik-Skrocka A
Cells. 2022; 11(22).
PMID: 36429127
PMC: 9688207.
DOI: 10.3390/cells11223699.
Notch-associated lncRNAs profiling circuiting epigenetic modification in colorectal cancer.
Emam O, Wasfey E, Hamdy N
Cancer Cell Int. 2022; 22(1):316.
PMID: 36229883
PMC: 9558410.
DOI: 10.1186/s12935-022-02736-2.
Concise review: Cancer cell reprogramming and therapeutic implications.
Xiao X, Chen H, Yang L, Xie G, Shimuzu R, Murai A
Transl Oncol. 2022; 24:101503.
PMID: 35933935
PMC: 9364012.
DOI: 10.1016/j.tranon.2022.101503.
Bioengineered miR-34a modulates mitochondrial inner membrane protein 17 like 2 (MPV17L2) expression toward the control of cancer cell mitochondrial functions.
Yi W, Tu M, Yu A, Lin J, Yu A
Bioengineered. 2022; 13(5):12489-12503.
PMID: 35579419
PMC: 9276019.
DOI: 10.1080/21655979.2022.2076399.
Upregulation of BMI1-suppressor miRNAs (miR-200c, miR-203) during terminal differentiation of colon epithelial cells.
Hisamori S, Mukohyama J, Koul S, Hayashi T, Rothenberg M, Maeda M
J Gastroenterol. 2022; 57(6):407-422.
PMID: 35244768
PMC: 10091510.
DOI: 10.1007/s00535-022-01865-9.
Fusobacterium nucleatum Promotes Colorectal Cancer Cell to Acquire Stem Cell-Like Features by Manipulating Lipid Droplet-Mediated Numb Degradation.
Liu H, Du J, Chao S, Li S, Cai H, Zhang H
Adv Sci (Weinh). 2022; 9(12):e2105222.
PMID: 35170250
PMC: 9035998.
DOI: 10.1002/advs.202105222.
LncRNAs, the Molecules Involved in Communications With Colorectal Cancer Stem Cells.
Fan B, Zhang Q, Wang N, Wang G
Front Oncol. 2022; 12:811374.
PMID: 35155247
PMC: 8829571.
DOI: 10.3389/fonc.2022.811374.
Nanoparticle-Based RNAi Therapeutics Targeting Cancer Stem Cells: Update and Prospective.
Tang Y, Chen Y, Zhang Z, Tang B, Zhou Z, Chen H
Pharmaceutics. 2021; 13(12).
PMID: 34959397
PMC: 8708448.
DOI: 10.3390/pharmaceutics13122116.
The role of non-coding RNAs in chemotherapy for gastrointestinal cancers.
Dashti F, Mirazimi S, Rabiei N, Fathazam R, Rabiei N, Piroozmand H
Mol Ther Nucleic Acids. 2021; 26:892-926.
PMID: 34760336
PMC: 8551789.
DOI: 10.1016/j.omtn.2021.10.004.
Targeting Notch to Maximize Chemotherapeutic Benefits: Rationale, Advanced Strategies, and Future Perspectives.
Zhdanovskaya N, Firrincieli M, Lazzari S, Pace E, Scribani Rossi P, Felli M
Cancers (Basel). 2021; 13(20).
PMID: 34680255
PMC: 8533696.
DOI: 10.3390/cancers13205106.